More Of The Same Medicine From The Fed
If you are ailing, and you take a medicine that doesn't work, do you up the dosage or try something else?
For Ben Bernanke and the Federal Reserve, the answer seems clear: More is always the way to go.
An open-ended commitment
In the meeting of the Federal Open Market Committee that concluded September 13, the Fed decided on another round of quantitative easing -- QE3, for those of you keeping score.
In essence, the Fed is lengthening its commitment to low interest rates. It is now saying that it sees a likelihood of keeping the Fed funds rate at "exceptionally low levels" at least through the middle of 2015. Also, in announcing that it will make additional purchases of mortgage-backed securities, the Fed did not use a timetable or total amount to describe the extent of this new program -- it merely made an open-ended commitment to purchase additional mortgage-backed securities at a pace of $40 billion per month.
Over the past year, the Fed has put a great deal of emphasis on how it communicates its policies, and it is significant that the Fed is now signalling that low interest rates are here to stay for the foreseeable future. Having lowered interest rates about as far as it can, the Fed is now hoping to get extra psychological mileage out of the message that people can expect these low rates to continue for a long time.Three problems with the policy
The stock market got a quick fix out of the announcement, but it is important not to confuse the market's interests with the broader well-being of the economy. There is some overlap, of course, but stock valuation formulas yield higher prices when interest rates are low. Given how short-sighted most stock investors are, the promise of more low interest rates is enough to spark a rally, regardless of whether it ultimately helps the economy.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV